Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Safety and pharmacokinetics of 3-MMC in healthy volunteers
NL-OMON53217Completed
- Sponsor
- Maastricht University
- Start
- Oct 2023
- Modality
- Small Molecules
- Countries
- 1
01
Overview
Open-label trial of 3-methylmethcathinone (4 arms), sponsored by Maastricht University. Primary endpoints: Safety profile and Pharmacokinetics. Started Oct 2023; status: completed.
02
Drugs
3-methylmethcathinone
Beyond the preview
Go deeper on NL-OMON53217.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NL-OMON53217.